Dr. Donald Durden
A renowned physician-scientist, Donald Durden, M.D., PhD., is Vice Chair for Research at UC San Diego’s Department of Pediatrics and Associate Director for Pediatric Oncology at the Moores UCSD Cancer Center. Durden’s most recent accomplishment is the development and initiation of a clinical trial of the first small molecule inhibitor of PI-3 kinase to enter human clinical trials in cancer.
Read full bio
The main focus of the Durden laboratory is analyzing mouse models for pediatric cancer in order to better understand signaling pathways that contribute to cancer cell growth. As a result, Durden et al hope to identify the most powerful drug targets for pediatric disease intervention.
More about our research >
Durden & Castellino Discover New Biomarker for Medulloblastoma Tumor Growth
La Jolla, July 14, 2010 – In an investigative study published in May 2010 Issue of PLoS One, Durden teamed up with Dr. Craig Castellino at Emory University to report a new role for the PI-3 kinase signaling pathway in a pediatric brain tumor.
Read more >>